Glaxo to bring physician educators in-house

GlaxoSmithKline (GSK) will hire doctors to educate their peers instead of paying external speakers.

This is one of several initiatives the firm is implementing after paying a $3B fine to settle allegations that it illegally promoted Paxil and Wellbutrin and failed to report safely data on Avandia.

The company will cease paying outside doctors for giving speeches and attending medical meetings by early 2016.

From other sites
Comments (1)
    , contributor
    Comments (3) | Send Message
    This could be a step in the right direction. GSK should offer these 'train the trainer' to doctors who actually work in the field to which these drugs administered. Then, together with their input and the actual clinical studies, promote these drugs with a caveat on this can instead of may cause the following . Always tell the public to' see their doctor wether it for them..
    17 Mar 2014, 02:30 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs